TAK
Takeda Pharmaceutical Co. Ltd. Sponsored ADR · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website akeda.com
- Employees(FY) 49095
- ISIN US8740602052
Performance
-1.94%
1W
-1.94%
1M
-6.45%
3M
-2.21%
6M
-6.18%
YTD
-17.6%
1Y
Profile
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
Investment Analysis Report: TAK
Overview
In this investment analysis report, we will delve into the financial statements of TAK, a pharmaceutical company in the Health Technology sector. We will analyze the Balance Sheets, Income Statements, and Cashflow Statements to gain insights into the company's financial health, growth prospects, profitabi...
Technical Analysis of TAK 2024-05-10
Overview:
In analyzing the technical indicators for TAK stock over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key indicators, we aim to offer valuable insights and recommendations for potential inves...
Recent News & Updates
- 2024-05-13 11:22
Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy(Pharmaceutical Technology)
- 2024-05-13 07:26
- 2024-05-13 06:00
- 2024-05-12 18:00
- 2024-05-10 09:30
Catalyst's New CEO Has Big Ideas For The Small Biotech(Investor's Business Daily)
- 2024-05-09 15:46
- 2024-05-09 10:03
Takeda tackles $900m restructuring plan after generics hurt annual profits(Pharmaceutical Technology)
- 2024-05-09 07:52
Takeda targets ‘efficiency’ in restructuring, pipeline cuts(BioPharma Dive)
- 2024-05-09 04:23
- 2024-05-09 02:56
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss(The Wall Street Journal)
- 2024-05-09 02:07
- 2024-05-08 18:52
- 2024-05-08 14:07
- 2024-05-08 07:51
Nikkei Up 0.2%, Led by Banks, Insurers(Yahoo Finance)
- 2024-05-07 21:04
- 2024-05-06 02:06
- 2024-04-29 09:35
- 2024-04-28 21:35
- 2024-04-26 10:06
- 2024-04-26 09:35
- 2024-04-26 08:30
- 2024-04-26 08:30
- 2024-04-25 21:35
- 2024-04-25 20:30
- 2024-04-25 20:30
- 2024-04-25 12:00
- 2024-04-25 11:40
- 2024-04-25 11:34
20 Fastest Growing Health Tech Companies in the World(Insider Monkey)
- 2024-04-25 09:40
- 2024-04-25 06:52
Page 1 of 7
previousnext